Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dexmedetomidine hydrochloride manufacturers

5 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

5 products found

dexmedetomidine hydrochloride

Solution for injection 0.2 mg , 0.1 mg - 2 ml , 1 ml , 50 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #12677
The company is a prominent pharmaceutical group established in 1971, dedicated to providing high-quality and effective healthcare products and services. With over 20 subsidiaries and more than 16,000 employees across major cities, the company emphasizes innovation and quality, operating four national R&D platforms. Recognized for its excellence, it has won multiple State Science and Technology Advancement Awards and holds international standards for Chinese medicinal materials included in the European Pharmacopoeia. The company focuses on quality-first and efficiency-priority principles, aiming to enhance health outcomes while continuously advancing in the global healthcare industry.

Manufacturer usually replies in 4 days

dexmedetomidine hydrochloride

Injection 0.2 mg - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064
This company appears to be a pharmaceutical manufacturer focusing on various healthcare solutions. They offer products across multiple categories including prescription medications, over-the-counter drugs, and possibly medical devices or supplements based on their website structure. The company emphasizes its global reach, serving markets in the EU and North America.

Manufacturer usually replies in 5 days

dexmedetomidine hydrochloride

Injection 200mcg/2ml, 80mcg/20ml ,200mcg/50ml ,400mcg/100ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA, TGA
Manufacturer #17216
This global pharmaceutical company, established in 1970, prioritizes research and development of innovative healthcare products. With a focus on oncology, metabolic diseases, autoimmune diseases, and cardiovascular diseases, they have developed 14 in-house innovative products and partnered with other companies to bring 2 more to market. They boast over 5,000 R&D personnel across fourteen global centers and subsidiaries in North America, the EU, Australia, and Japan. Their commitment to innovation is evidenced by over 90 innovative drug candidates in development and nearly 20 undergoing clinical trials worldwide. The company holds numerous patents granted in key regions like the US, EU, and Japan, demonstrating their strong intellectual property portfolio. They manufacture products that meet or exceed European Union and US Pharmacopoeia standards, exporting to markets including the US, EU, and Japan.

Manufacturer usually replies in 19 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is DEXMEDETOMIDINE HYDROCHLORIDE?

Dexmedetomidine is a pharmaceutical substance that is sold under the trade name Precedex amongst others, is an anxiety-reducing, sedative, and pain medicine. This pharmaceutical drug is well-known for its capacity to provide sedation outdoors risk of respiratory depression (unlike other generally used drugs such as propofol and fentanyl) and can provide usefulness or semi-rousable sedation. Similar to clonidine, it is a sympatholytic drug that acts as an agonist of α2-adrenergic receptors insecure parts of the cerebrum. Veterinarians use dexmedetomidine for comparable purposes in treating kittens, dogs, and horses. It was revealed by Orion Pharma. Dexmedetomidine is everywhere frequently practiced in the intensive care setting for light to modest sedation. It is not approved for long-term heartfelt sedation. A biography of dexmedetomidine is that it has analgesic characteristics in addition to its capacity as an anesthetic, but is opioid-sparing; thus, it is not associated with significant respiratory difficulty(unlike propofol). Many studies recommend dexmedetomidine for sedation in mechanically ventilated adults may reduce the time to extubation and ICU sojourn. Characters on dexmedetomidine can be rousable and cooperative, an advantage in some schemes. Compared amidst other sedatives, some considerations suggest dexmedetomidine may be associated with less delirium. Nevertheless, this finding is not compatible across multiple schoolrooms. At the very least, when aggregating many study decisions together, the use of dexmedetomidine resembles to be associated with less neurocognitive dysfunction examined to other sedatives. Whether this observation has a beneficial psychological impact is unclear. From an economic perspective, this pharmaceutical medicine is associated with lower ICU costs, mainly due to a more diminutive time to extubation. Intravenous immersion of dexmedetomidine is commonly initiated with a loading dose followed by a continuance infusion. There may be great individual variability in the hemodynamic effects (especially on heart rate and blood pressure), as well as the sedative effects of this drug. For this reason, the dose must be carefully adjusted to achieve the desired clinical effect. There is no absolute contraindication to the use of dexmedetomidine. It has a biphasic effect on blood pressure with lower sections at lower drug combinations and higher readings at higher intensities. Rapid IV administration or bolus has been associated with hypertension due to peripheral α2-receptor stimulation. Bradycardia can be a limiting factor with infusions, especially in higher doses.

How does it DEXMEDETOMIDINE HYDROCHLORIDE work?

Similar to clonidine, it is a sympatholytic medication that functions as an agonist of α2-adrenergic receptors in particular parts of the brain. Veterinarians use dexmedetomidine for similar purposes in treating cats, dogs, and horses.

The Wholesale Price of DEXMEDETOMIDINE HYDROCHLORIDE

The cost for dexmedetomidine intravenous solution (4 mcg/mL-NaCl 0.9%) is around $228 for a supply of 200 milliliters, depending on the pharmacy you visit.

Sourcing DEXMEDETOMIDINE HYDROCHLORIDE Manufacturers and Suppliers

PipelinePharma has found 7 verified dexmedetomidine hydrochloride manufacturers and dexmedetomidine hydrochloride suppliers from our global list of sellers. The pharmaceutical drug is available for sale in various forms such as injection, solution for injection, vials, ampoules from manufacturers in various countries including China, India, Turkey.

Navigating our pharmaceutical marketplace

PipelinePharma is a global B2B pharmaceutical online marketplace. Pipelinepharma is structured so as to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of dexmedetomidine hydrochloride offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible